Adjuvant Chemoradiotherapy May Boost Endometrial-Cancer Survival Adjuvant Chemoradiotherapy May Boost Endometrial-Cancer Survival
Combined adjuvant chemotherapy and radiotherapy appear significantly more effective than pelvic radiotherapy alone for women with high-risk endometrial cancer, according to a post hoc analysis of the PORTEC-3 trial.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Endometrial Cancer | Health | Hematology | Women